Aurinia Pharmaceuticals Inc. Registered Shares o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

79.63%

Market Cap

669.21 Mil.

P/E Ratio

7.70

Dividend Yield

0.00 %

Earnings per Share

1.84 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORM
LAST PRICE13.625 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:46:57 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW13.62513.255
PREV. DAY'S PRICE13.415 (07/20)
CHANGE DAY BEFORE
+0.21
1.57 %
52 WEEK HIGH / LOW16.77 (06/24)7.3 (07/22)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.500.041.840.861.08
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-228.507.7016.2912.98
PRICE - BOOK RATIO
3.423.353.63--
PRICE - SALES RATIO
7.345.587.82--
PRICE - CASH FLOW RATIO
-29.5816.31--
Further Key Figures

Master Data

WKN
A1W7D4
ISIN
CA05156V1022
SYMBOL
IKAP
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
AURINIA PHARMACEUT.
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
144.62 Mil.
MARKET CAPITALISATION
669.21 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.82 %
-5.53 %
-0.59 %
6.89 %
79.63 %
33.88 %
37.34 %
0.49 %
HIGH14.1416.7716.7716.7716.7716.7729.5116.77
LOW13.4013.2612.2211.507.304.443.8311.50

Dividende

pro Aktie
AURINIA PHARMACEUT. does not deliver dividend information

Company profile

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.